Manufacturing

Jorge Ferreira is fill/finish subject matter expert at Jacobs, 

Lora Zeanchock is project manager at Jacobs.

Articles

Scenario modeling informs planning for current and future manufacturing needs. 

Designing Flexible Fill/Finish Facilities

Amgen’s greenfield facility near Columbus, Ohio to assemble and package vials and syringes is expected to be operational by 2024. 

Amgen Builds Packaging Facility in Ohio

Hallie Forcinio is BioPharm International's packaging editor, editorhal@sbcglobal.net

Container and equipment innovations expand applications. 

Innovations Meet Growing Demand for Prefilled Syringes 

The new line can fill prefilled syringes, cartridges, and vials using ready-to-use components.

Aji Bio-Pharma to Add High Speed Fill/Finish Line to its San Diego Facility

Samsung Biologics plans to support the production of hundreds of millions of doses of Moderna’s vaccine to supply to markets outside of the United States beginning in the third quarter of 2021. 

Moderna and Samsung Biologics Partner on Fill/Finish Manufacturing of Moderna’s COVID-19 Vaccine

BioNTech plans to expand its global footprint by establishing its regional headquarters for southeast Asia and a new mRNA manufacturing facility in Singapore. 

BioNTech to Establish Regional Headquarters and mRNA Manufacturing Facility in Singapore

Andrea Sardella, PhD, is pharma inspection product development manager for Stevanato Group, 

A best practices approach to pharma’s most challenging-to-inspect container. 

The Ins and Outs of Syringe Inspection

Moderna’s investments will double the formulation fill/finish and drug substance manufacturing of its vaccine to up to three billion doses in 2022 at various manufacturing sites. 

Moderna Announces Additional Investments to Increase COVID-19 Vaccine Supply for 2022

Sanofi will perform the fill/finish of up to 200 million doses of Moderna’s COVID-19 vaccine at its Ridgefield, NJ, facility starting in September 2021. 

Sanofi to Manufacture up to 200 Million Doses of Moderna’s COVID-19 Vaccine

Under the terms of the expanded agreement, Catalent will provide Moderna with a new high-speed vial filling line until June 2023 along with inspection, labeling, cartoning, and final packaging for potential pipeline programs.

Manufacturing, Fill/Finish